Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia

References

• Lawrence JJ. Cholinergic control of GABA release: emerging parallels between neocortex and hippocampus. Trends Neurosci 2008; 31:317 - 27; http://dx.doi.org/10.1016/j.tins.2008.03.008; PMID: 18556072
   PubMed Web of Science ®Google Scholar
• Fisahn A, Yamada M, Duttaroy A, Gan J-W, Deng C-X, McBain CJ, et al. Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation currents. Neuron 2002; 33:615 - 24; http://dx.doi.org/10.1016/S0896-6273(02)00587-1; PMID: 11856534
   PubMed Web of Science ®Google Scholar
• Chiang PH, Yeh WC, Lee CT, Weng JY, Huang YY, Lien CC. M(1)-like muscarinic acetylcholine receptors regulate fast-spiking interneuron excitability in rat dentate gyrus. Neuroscience 2010; 169:39 - 51; http://dx.doi.org/10.1016/j.neuroscience.2010.04.051; PMID: 20433901
   PubMed Web of Science ®Google Scholar
• Lee K-H, Williams LM, Breakspear M, Gordon E. Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Res Brain Res Rev 2003; 41:57 - 78; http://dx.doi.org/10.1016/S0165-0173(02)00220-5; PMID: 12505648
   PubMed Web of Science ®Google Scholar
• Uhlhaas PJ, Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 2010; 11:100 - 13; http://dx.doi.org/10.1038/nrn2774; PMID: 20087360
   PubMed Web of Science ®Google Scholar
• Verret L, Mann EO, Hang GB, Barth AMI, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 2012; 149:708 - 21; http://dx.doi.org/10.1016/j.cell.2012.02.046; PMID: 22541439
   PubMed Web of Science ®Google Scholar
• Delmas P, Brown DA. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 2005; 6:850 - 62; http://dx.doi.org/10.1038/nrn1785; PMID: 16261179
   PubMed Web of Science ®Google Scholar
• Congar P, Leinekugel X, Ben-Ari Y, Crépel V. A long-lasting calcium-activated nonselective cationic current is generated by synaptic stimulation or exogenous activation of group I metabotropic glutamate receptors in CA1 pyramidal neurons. J Neurosci 1997; 17:5366 - 79; PMID: 9204921
   PubMed Web of Science ®Google Scholar
• Ross CA, Margolis RL, Reading SAJ, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron 2006; 52:139 - 53; http://dx.doi.org/10.1016/j.neuron.2006.09.015; PMID: 17015232
   PubMed Web of Science ®Google Scholar
• Curley AA, Lewis DA. Cortical basket cell dysfunction in schizophrenia. J Physiol 2012; 590:715 - 24; PMID: 22219337
   PubMed Web of Science ®Google Scholar
• Coyle JT. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006; 26:365 - 84; http://dx.doi.org/10.1007/s10571-006-9062-8; PMID: 16773445
   PubMed Web of Science ®Google Scholar
• Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?. Brain Res Bull 2010; 83:108 - 21; http://dx.doi.org/10.1016/j.brainresbull.2010.04.006; PMID: 20417696
   PubMed Web of Science ®Google Scholar
• Gonzalez-Burgos G, Lewis DA. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull 2008; 34:944 - 61; http://dx.doi.org/10.1093/schbul/sbn070; PMID: 18586694
   PubMed Web of Science ®Google Scholar
• Behrens MM, Sejnowski TJ. Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?. Neuropharmacology 2009; 57:193 - 200; http://dx.doi.org/10.1016/j.neuropharm.2009.06.002; PMID: 19523965
   PubMed Web of Science ®Google Scholar
• Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 2009; 19:220 - 30; http://dx.doi.org/10.1016/j.conb.2009.05.001; PMID: 19481443
   PubMed Web of Science ®Google Scholar
• Hardingham GE, Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 2010; 11:682 - 96; http://dx.doi.org/10.1038/nrn2911; PMID: 20842175
   PubMed Web of Science ®Google Scholar
• Berk M, Ng F, Dean O, Dodd S, Bush AI. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci 2008; 29:346 - 51; http://dx.doi.org/10.1016/j.tips.2008.05.001; PMID: 18538422
   PubMed Web of Science ®Google Scholar
• Sharma G, Vijayaraghavan S. Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing. Neuron 2003; 38:929 - 39; http://dx.doi.org/10.1016/S0896-6273(03)00322-2; PMID: 12818178
   PubMed Web of Science ®Google Scholar
• Pitcher GM, Kalia LV, Ng D, Goodfellow NM, Yee KT, Lambe EK, et al. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat Med 2011; 17:470 - 8; http://dx.doi.org/10.1038/nm.2315; PMID: 21441918
   PubMed Web of Science ®Google Scholar
• Li X, Jope RS. Is glycogen synthase kinase-3 a central modulator in mood regulation?. Neuropsychopharmacology 2010; 35:2143 - 54; http://dx.doi.org/10.1038/npp.2010.105; PMID: 20668436
   PubMed Web of Science ®Google Scholar
• Vacic V, McCarthy S, Malhotra D, Murray F, Chou H-H, Peoples A, et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 2011; 471:499 - 503; http://dx.doi.org/10.1038/nature09884; PMID: 21346763
   PubMed Web of Science ®Google Scholar
• Lee K-H, Williams LM, Breakspear M, Gordon E. Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Res Brain Res Rev 2003; 41:57 - 78; http://dx.doi.org/10.1016/S0165-0173(02)00220-5; PMID: 12505648
   PubMed Web of Science ®Google Scholar
• Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 2011; 12:524 - 38; http://dx.doi.org/10.1038/nrn3044; PMID: 21852800
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Manji HK, Zarate CA Jr.. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 2009; 11:Suppl 2 92 - 109; http://dx.doi.org/10.1111/j.1399-5618.2009.00714.x; PMID: 19538689
   PubMed Web of Science ®Google Scholar
• Quiroz JA, Machado-Vieira R, Zarate CA Jr., Manji HK. Novel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 2010; 62:50 - 60; http://dx.doi.org/10.1159/000314310; PMID: 20453535
   PubMed Web of Science ®Google Scholar
• Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK, et al. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3β/β-catenin signaling. Cell 2009; 136:1017 - 31; http://dx.doi.org/10.1016/j.cell.2008.12.044; PMID: 19303846
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Pivovarova NB, Stanika RI, Yuan P, Wang Y, Zhou R, et al. The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. Biol Psychiatry 2011; 69:344 - 52; http://dx.doi.org/10.1016/j.biopsych.2010.10.019; PMID: 21167476
   PubMed Web of Science ®Google Scholar
• Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999; 72:879 - 82; http://dx.doi.org/10.1046/j.1471-4159.1999.720879.x; PMID: 9930766
   PubMed Web of Science ®Google Scholar
• Rong YP, Distelhorst CW. Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Annu Rev Physiol 2008; 70:73 - 91; http://dx.doi.org/10.1146/annurev.physiol.70.021507.105852; PMID: 17680735
   PubMed Web of Science ®Google Scholar
• Warsh JJ, Andreopoulos S, Li PP. Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status. Clin Neurosci Res 2004; 4:201 - 13; http://dx.doi.org/10.1016/j.cnr.2004.09.012
   Web of Science ®Google Scholar
• Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: a unifying hypothesis. Cell 1989; 59:411 - 9; http://dx.doi.org/10.1016/0092-8674(89)90026-3; PMID: 2553271
   PubMed Web of Science ®Google Scholar
• Kim HJ, Thayer SA. Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol Pharmacol 2009; 75:1021 - 30; http://dx.doi.org/10.1124/mol.108.052357; PMID: 19188338
   PubMed Web of Science ®Google Scholar
• Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008; 13:197 - 207; http://dx.doi.org/10.1038/sj.mp.4002012; PMID: 17486107
   PubMed Web of Science ®Google Scholar
• Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, Lidow MS. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci U S A 2003; 100:313 - 7; http://dx.doi.org/10.1073/pnas.232693499; PMID: 12496348
   PubMed Web of Science ®Google Scholar
• Schlecker C, Boehmerle W, Jeromin A, DeGray B, Varshney A, Sharma Y, et al. Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest 2006; 116:1668 - 74; http://dx.doi.org/10.1172/JCI22466; PMID: 16691292
   PubMed Web of Science ®Google Scholar
• Kabbani N, Negyessy L, Lin RW, Goldman-Rakic P, Levenson R. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 2002; 22:8476 - 86; PMID: 12351722
   PubMed Web of Science ®Google Scholar
• Sayas CL, Ariaens A, Ponsioen B, Moolenaar WH. GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction. Mol Biol Cell 2006; 17:1834 - 44; http://dx.doi.org/10.1091/mbc.E05-07-0688; PMID: 16452634
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297:353 - 6; http://dx.doi.org/10.1126/science.1072994; PMID: 12130773
   PubMed Web of Science ®Google Scholar
• Khachaturian ZS. Calcium, membranes, aging, and Alzheimer’s disease. Introduction and overview. Ann N Y Acad Sci 1989; 568:1 - 4; http://dx.doi.org/10.1111/j.1749-6632.1989.tb12485.x; PMID: 2629579
   PubMed Web of Science ®Google Scholar
• LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 2002; 3:862 - 72; http://dx.doi.org/10.1038/nrn960; PMID: 12415294
   PubMed Web of Science ®Google Scholar
• Stutzmann GE. The pathogenesis of Alzheimers disease is it a lifelong “calciumopathy”?. Neuroscientist 2007; 13:546 - 59; http://dx.doi.org/10.1177/1073858407299730; PMID: 17901262
   PubMed Web of Science ®Google Scholar
• Thibault O, Gant JC, Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer’s disease: minding the store. Aging Cell 2007; 6:307 - 17; http://dx.doi.org/10.1111/j.1474-9726.2007.00295.x; PMID: 17465978
   PubMed Web of Science ®Google Scholar
• Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu H-Y, Hyman BT, Bacskai BJA. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 2008; 59:214 - 25; http://dx.doi.org/10.1016/j.neuron.2008.06.008; PMID: 18667150
   PubMed Web of Science ®Google Scholar
• Lopez JR, Lyckman A, Oddo S, Laferla FM, Querfurth HW, Shtifman A. Increased intraneuronal resting [Ca2+] in adult Alzheimer’s disease mice. J Neurochem 2008; 105:262 - 71; http://dx.doi.org/10.1111/j.1471-4159.2007.05135.x; PMID: 18021291
   PubMed Web of Science ®Google Scholar
• Bezprozvanny I, Mattson MP. Neuronal calcium mishandling and the pathogenesis of Alzheimer’s disease. Trends Neurosci 2008; 31:454 - 63; http://dx.doi.org/10.1016/j.tins.2008.06.005; PMID: 18675468
   PubMed Web of Science ®Google Scholar
• Sanz-Blasco S, Valero RA, Rodríguez-Crespo I, Villalobos C, Núñez L. Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS One 2008; 3:e2718; http://dx.doi.org/10.1371/journal.pone.0002718; PMID: 18648507
   PubMed Web of Science ®Google Scholar
• Shirwany NA, Payette D, Xie J, Guo Q. The amyloid beta ion channel hypothesis of Alzheimer’s disease. Neuropsychiatr Dis Treat 2007; 3:597 - 612; PMID: 19300589
   PubMedGoogle Scholar
• Demuro A, Smith M, Parker I. Single-channel Ca(2+) imaging implicates Aβ1-42 amyloid pores in Alzheimer’s disease pathology. J Cell Biol 2011; 195:515 - 24; http://dx.doi.org/10.1083/jcb.201104133; PMID: 22024165
   PubMed Web of Science ®Google Scholar
• Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Cell Calcium 2012; 51:95 - 106; http://dx.doi.org/10.1016/j.ceca.2011.11.008; PMID: 22177709
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Guo Q, Furukawa K, Sopher BL, Pham DG, Xie J, Robinson N, et al. Alzheimer’s PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 1996; 8:379 - 83; http://dx.doi.org/10.1097/00001756-199612200-00074; PMID: 9051814
   PubMed Web of Science ®Google Scholar
• Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer’s disease mice. J Neurosci 2006; 26:5180 - 9; http://dx.doi.org/10.1523/JNEUROSCI.0739-06.2006; PMID: 16687509
   PubMed Web of Science ®Google Scholar
• Supnet C, Grant J, Kong H, Westaway D, Mayne M. Amyloid-β-(1-42) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice. J Biol Chem 2006; 281:38440 - 7; http://dx.doi.org/10.1074/jbc.M606736200; PMID: 17050533
   PubMed Web of Science ®Google Scholar
• Chan SL, Mayne M, Holden CP, Geiger JD, Mattson MP. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J Biol Chem 2000; 275:18195 - 200; http://dx.doi.org/10.1074/jbc.M000040200; PMID: 10764737
   PubMed Web of Science ®Google Scholar
• Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer’s disease. J Neurochem 2005; 94:1711 - 8; http://dx.doi.org/10.1111/j.1471-4159.2005.03332.x; PMID: 16156741
   PubMed Web of Science ®Google Scholar
• Chakroborty S, Goussakov I, Miller MB, Stutzmann GE. Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. J Neurosci 2009; 29:9458 - 70; http://dx.doi.org/10.1523/JNEUROSCI.2047-09.2009; PMID: 19641109
   PubMed Web of Science ®Google Scholar
• Goussakov I, Miller MB, Stutzmann GE. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer’s disease mice. J Neurosci 2010; 30:12128 - 37; http://dx.doi.org/10.1523/JNEUROSCI.2474-10.2010; PMID: 20826675
   PubMed Web of Science ®Google Scholar
• Green KN, Demuro A, Akbari Y, Hitt BD, Smith IF, Parker I, et al. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production. J Cell Biol 2008; 181:1107 - 16; http://dx.doi.org/10.1083/jcb.200706171; PMID: 18591429
   PubMed Web of Science ®Google Scholar
• Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, et al. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer’s disease-linked mutations. Cell 2006; 126:981 - 93; http://dx.doi.org/10.1016/j.cell.2006.06.059; PMID: 16959576
   PubMed Web of Science ®Google Scholar
• Cheung KH, Shineman D, Müller M, Cárdenas C, Mei L, Yang J, et al. Mechanism of Ca2+ disruption in Alzheimer’s disease by presenilin regulation of InsP3 receptor channel gating. Neuron 2008; 58:871 - 83; http://dx.doi.org/10.1016/j.neuron.2008.04.015; PMID: 18579078
   PubMed Web of Science ®Google Scholar
• Müller M, Cárdenas C, Mei L, Cheung KH, Foskett JK. Constitutive cAMP response element binding protein (CREB) activation by Alzheimer’s disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling. Proc Natl Acad Sci U S A 2011; 108:13293 - 8; http://dx.doi.org/10.1073/pnas.1109297108; PMID: 21784978
   PubMed Web of Science ®Google Scholar
• Palop JJ, Jones B, Kekonius L, Chin J, Yu G-Q, Raber J, et al. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer’s disease-related cognitive deficits. Proc Natl Acad Sci U S A 2003; 100:9572 - 7; http://dx.doi.org/10.1073/pnas.1133381100; PMID: 12881482
   PubMed Web of Science ®Google Scholar
• Geula C, Bu J, Nagykery N, Scinto LFM, Chan J, Joseph J, et al. Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss. J Comp Neurol 2003; 455:249 - 59; http://dx.doi.org/10.1002/cne.10475; PMID: 12454989
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Calcium hypothesis of Alzheimer’s disease. Pflugers Arch 2010; 459:441 - 9; http://dx.doi.org/10.1007/s00424-009-0736-1; PMID: 19795132
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Calcium signalling and Alzheimer’s disease. Neurochem Res 2011; 36:1149 - 56; http://dx.doi.org/10.1007/s11064-010-0371-4; PMID: 21184278
   PubMed Web of Science ®Google Scholar
• Nunes PV, Forlenza OV, Gattaz WF. Lithium and risk for Alzheimer’s disease in elderly patients with bipolar disorder. Br J Psychiatry 2007; 190:359 - 60; http://dx.doi.org/10.1192/bjp.bp.106.029868; PMID: 17401045
   PubMed Web of Science ®Google Scholar
• Rohn TT, Vyas V, Hernandez-Estrada T, Nichol KE, Christie L-A, Head E. Lack of pathology in a triple transgenic mouse model of Alzheimer’s disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci 2008; 28:3051 - 9; http://dx.doi.org/10.1523/JNEUROSCI.5620-07.2008; PMID: 18354008
   PubMed Web of Science ®Google Scholar
• Dineley KT, Hogan D, Zhang WR, Taglialatela G. Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem 2007; 88:217 - 24; http://dx.doi.org/10.1016/j.nlm.2007.03.010; PMID: 17521929
   PubMed Web of Science ®Google Scholar
• Foster TC, Sharrow KM, Masse JR, Norris CM, Kumar A. Calcineurin links Ca2+ dysregulation with brain aging. J Neurosci 2001; 21:4066 - 73; PMID: 11356894
   PubMed Web of Science ®Google Scholar
• Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13:100 - 5; http://dx.doi.org/10.1016/S1043-2760(01)00547-1; PMID: 11893522
   PubMed Web of Science ®Google Scholar
• Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A. Vitamin D, nervous system and aging. Psychoneuroendocrinology 2009; 34:Suppl 1 S278 - 86; http://dx.doi.org/10.1016/j.psyneuen.2009.07.003; PMID: 19660871
   PubMedGoogle Scholar
• Wang L, Hara K, Van Baaren JM, Price JC, Beecham GW, Gallins PJ, et al. Vitamin D receptor and Alzheimer’s disease: a genetic and functional study. Neurobiol Aging 2012; 33:1844.e1 - 9; http://dx.doi.org/10.1016/j.neurobiolaging.2011.12.038; PMID: 22306846
   PubMedGoogle Scholar
• Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007; 460:202 - 5; http://dx.doi.org/10.1016/j.abb.2006.12.018; PMID: 17258168
   PubMed Web of Science ®Google Scholar
• Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Herrmann FR, et al. Higher vitamin D dietary intake is associated with lower risk of Alzheimer’s disease: A 7-year follow-up. J Gerontol A Biol Sci Med Sci 2012; In Press http://dx.doi.org/10.1093/gerona/gls107; PMID: 22503994
   PubMed Web of Science ®Google Scholar
• Annweiler C, Beauchet O. Possibility of a new anti-alzheimer’s disease pharmaceutical composition combining memantine and vitamin D. Drugs Aging 2012; 29:81 - 91; http://dx.doi.org/10.2165/11597550-000000000-00000; PMID: 22233455
   PubMed Web of Science ®Google Scholar
• Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, et al. Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet 2011; 75:201 - 10; http://dx.doi.org/10.1111/j.1469-1809.2010.00631.x; PMID: 21309754
   PubMed Web of Science ®Google Scholar
• Kesby JP, Eyles DW, Burne TH, McGrath JJ. The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol 2011; 347:121 - 7; http://dx.doi.org/10.1016/j.mce.2011.05.014; PMID: 21664231
   PubMed Web of Science ®Google Scholar
• Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RG, van Heemst D. VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 2009; 30:466 - 73; http://dx.doi.org/10.1016/j.neurobiolaging.2007.07.001; PMID: 17714831
   PubMed Web of Science ®Google Scholar
• Lehmann DJ, Refsum H, Warden DR, Medway C, Wilcock GK, Smith AD. The vitamin D receptor gene is associated with Alzheimer’s disease. Neurosci Lett 2011; 504:79 - 82; http://dx.doi.org/10.1016/j.neulet.2011.08.057; PMID: 21911036
   PubMed Web of Science ®Google Scholar
• Chan CS, Gertler TS, Surmeier DJ. Calcium homeostasis, selective vulnerability and Parkinson’s disease. Trends Neurosci 2009; 32:249 - 56; http://dx.doi.org/10.1016/j.tins.2009.01.006; PMID: 19307031
   PubMed Web of Science ®Google Scholar
• Wang JY, Wu J-N, Cherng T-L, Hoffer BJ, Chen H-H, Borlongan CV, et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res 2001; 904:67 - 75; http://dx.doi.org/10.1016/S0006-8993(01)02450-7; PMID: 11516412
   PubMed Web of Science ®Google Scholar
• de Viragh PA, Haglid KG, Celio MR. Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci U S A 1989; 86:3887 - 90; http://dx.doi.org/10.1073/pnas.86.10.3887; PMID: 2542952
   PubMed Web of Science ®Google Scholar
• Wasserman RH. Vitamin D and the dual processes of intestinal calcium absorption. J Nutr 2004; 134:3137 - 9; PMID: 15514288
   PubMed Web of Science ®Google Scholar
• Pérez AV, Picotto G, Carpentieri AR, Rivoira MA, Peralta López ME, Tolosa de Talamoni NG. Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway. Digestion 2008; 77:22 - 34; PMID: 18277073
   PubMed Web of Science ®Google Scholar
• Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992; 13:239 - 50; http://dx.doi.org/10.1016/0169-328X(92)90032-7; PMID: 1317496
   PubMedGoogle Scholar
• Brewer LD, Porter NM, Kerr DS, Landfield PW, Thibault O. Chronic 1α,25-(OH)2 vitamin D3 treatment reduces Ca2+ -mediated hippocampal biomarkers of aging. Cell Calcium 2006; 40:277 - 86; http://dx.doi.org/10.1016/j.ceca.2006.04.001; PMID: 16780945
   PubMed Web of Science ®Google Scholar